Showing 1 posts of 1 posts found.
Excipient specialist Colorcon buys an Indian rival, FDA gets tough on unapproved drugs plus facility updates from Farmar, ATMI and …
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
Highlighting the value of lab research for healthcare innovation
Capital Dynamics invests €14m in Italian community healthcare platform CareHub
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO